Roche`s xCELLigence System Monitors Beating Periodicity of Stem Cell Derived Cardiomyocytes in ...
Penzberg, Germany, September 15, 2011 / B3C newswire / - Cardiac toxicity is a major concern in drug development and it is imperative that clinical candidates are thoroughly tested for adverse effects earlier in the drug discovery process. In a new …